Item 9 Labs Corp. (INLB) SEC Filing 8-K Material Event for the period ending Tuesday, February 1, 2022

Item 9 Labs Corp.

CIK: 1500123 Ticker: INLB

View differences made from one to another to evaluate Item 9 Labs Corp.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Item 9 Labs Corp..


Assess how Item 9 Labs Corp.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Item 9 Labs Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Ticker: INLB
CIK: 1500123
Form Type: 8-K Corporate News
Accession Number: 0001554795-22-000043
Submitted to the SEC: Tue Feb 01 2022 5:49:46 PM EST
Accepted by the SEC: Wed Feb 02 2022
Period: Tuesday, February 1, 2022
Industry: Dental Equipment And Supplies
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: